| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
10% |
19.3 |
12.6 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
8% |
19.3 |
11.9 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
6% |
19.3 |
12.3 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
4% |
19.3 |
13.2 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
2% |
19.3 |
14.2 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
30% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
25% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
20% |
19.3 |
6.7 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
15% |
19.3 |
11.1 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
10% |
19.3 |
10.8 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
8% |
19.3 |
13.1 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
6% |
19.3 |
13.6 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
4% |
19.3 |
13.8 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
2% |
19.3 |
15.1 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
30% |
19.3 |
0.5 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
25% |
19.3 |
0.6 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
20% |
19.3 |
0.8 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
15% |
19.3 |
1.2 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
8% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
10% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
8% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
6% |
19.3 |
0.3 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
4% |
19.3 |
0.4 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
2% |
19.3 |
0.4 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
1% |
19.3 |
1.1 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
0.5% |
19.3 |
5.4 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
10% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
10% |
19.3 |
3.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
6% |
19.3 |
0.3 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
4% |
19.3 |
0.4 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
2% |
19.3 |
6.2 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
1% |
19.3 |
15.8 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Tetrahydrofuran (THF) |
0.5% |
19.3 |
17.8 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
25% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
20% |
19.3 |
5.4 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Isopropanol |
15% |
19.3 |
10.1 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
2% |
19.3 |
16.2 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
30% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
25% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
20% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
15% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
10% |
19.3 |
12.7 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
8% |
19.3 |
13.6 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
6% |
19.3 |
14.4 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
4% |
19.3 |
15.1 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
2% |
19.3 |
8.9 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
30% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
25% |
19.3 |
0.8 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
20% |
19.3 |
6.7 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
15% |
19.3 |
10.7 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
10% |
19.3 |
10.8 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
8% |
19.3 |
13.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
6% |
19.3 |
13.4 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
4% |
19.3 |
13.9 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
8% |
19.3 |
1.3 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
5% |
19.3 |
4.5 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
30% |
19.3 |
3.6 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
25% |
19.3 |
3.9 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
20% |
19.3 |
3.9 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
15% |
19.3 |
5.6 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
10% |
19.3 |
5.5 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Ethyl Acetate |
5% |
19.3 |
12.1 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
10% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
Acetonitrile |
2% |
19.3 |
14.5 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
6% |
19.3 |
12.7 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
4% |
19.3 |
13.5 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
2% |
19.3 |
14.5 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, with 4.8 mM TPP and 18 mM MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
10% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
8% |
19.3 |
0.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
6% |
19.3 |
0.6 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |
| Stability - Incubation |
Activity after incubation (3 hours at 25Β°C), measured by HPLC in aquous conditions |
1-Butanol |
4% |
19.3 |
6.0 |
Β΅M/mg/mL |
Incubation: 50 mM Tris-HCl buffer, without TPP or MgClβ, Assay: 50 mM Tris-HCl buffer, 2.4 mM TPP, 9 mM MgClβ |
Incubation: 7, Assay: 7 |
Incubation: 25Β°C, Assay: 25Β°C |
50 mM Glycoaldehyde, 50 mM Hydroxypyruvic acid |
Carbon Dioxide (CO2), Erythrulose |
Assay: 2.4 mM TPP, 9 mM MgClβ |
Incubation: 1000 rpm |
Non-incubated control (in Β΅M/mg/mL), assay in aqueous phase | Clear about assay in diluted aqueous phase/Goal of article : comparison residual activity when incubated with and without cofactors |